Abacavirum, Lamivudinum
| Medicinal product name | Abacavir/Lamivudine Accord 600 mg/300 mg film-coated tablets |
|---|---|
| Pharmaceutical form | Film-coated tablet |
| Strength | 600 mg/300 mg |
| Information from the MAH on shortages |
Not available predicted availability date: May 30, 2024 |
| Legal status | Prescription (Pr.) Reimbursed medicines reference product |
| Package leaflet |  28-11-2023
|
| Summary of product characteristics | 28-11-2023
|
| Risk minimisation measures | Izglītojošie materiāli ārstam Izglītojošie materiāli pacientam |
| ATC code | J05AR02 – Antivirals for systemic use |
| Information for Marketing authorisation holders | View |
Medicinal products (3)
| Availability of medicinal product | Wholesalers | Package size, content | Primary packaging | Maximum admissible pharmacy price (€ incl. VAT) | Product No. | Labelling |
|---|---|---|---|---|---|---|
|
Not available (according to the information provided by wholesalers) predicted availability date: May 30, 2024 |
currently no information on availability from any wholesaler |
N30 (600 mg/300 mg) |
PVDC/PE/PVC/Al blister |
€ 56.45 * |
16-0089-01 |
 Labelling text Jul 18, 2019 |
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N90: 3 × 30 (600 mg/300 mg) |
PVDC/PE/PVC/Al blister | 16-0089-02 |
Labelling text Jul 18, 2019 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N30 (600 mg/300 mg) |
HDPE bottle | 16-0089-03 |
Labelling text Jul 18, 2019 |
* Indication about medicine on the List of state reimbursed medicines is just informative. Source of the information is the National Health Service. For details please visit the NHS website.
Registration information
| Marketing authorisation No. | 16-0089 |
|---|---|
| Date of authorisation | May 17, 2016 |
| Marketing authorisation holder, country | Accord Healthcare B.V., Netherlands |
